Cmv-Complement Fixation Antigen and Negative Contr

FDA 510(k) K852929 · Microbix Biosystems, Inc.

Substantially Equivalent

510(k) numberK852929

Submission

Device name
Cmv-Complement Fixation Antigen and Negative Contr
Applicant
Microbix Biosystems, Inc.
Canada, CA
Received
July 9, 1985
Decision date
November 12, 1985
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
GQI – Antiserum, Cf, Cytomegalovirus
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3175
Specialty
Microbiology

Other 510(k)s with product code GQI

510(k)DeviceApplicantDecision
K952254Enzyme Linked Immunoabsorbent Assay, CytomegalovirusGQI · Traditional Pyramid Biological Corp.11/16/1995SE
K951800CMV Igg Human Serum ControlsGQI · Traditional Pyramid Biological Corp.11/16/1995SE
K942171CMV Early Antigen TestGQI · Traditional Neogenex06/30/1994SE
K883102Virgo (R) Cmv-Igg ElisaGQI · Traditional Electro-Nucleonics, Inc.02/08/1989SE
K875159Detectadot System 2000 CMV Igg TestGQI · Traditional Gull Laboratories, Inc.05/06/1988SE
K863488Enzygnost Anti-Cmv Igg TestGQI · Traditional Behring Diagnostics, Inc.07/20/1987SE
K864420CMV MicroassayGQI · Traditional Diamedix Corp.02/02/1987SE
K861123The Golden Quad Test (CMV)GQI · Traditional Microbiological Research Corp.02/02/1987SE
K862705Cytomegalovirus Igg Eia Test KitGQI · Traditional Labsystems, Inc.10/01/1986SE
K853989Cor Dot CMVGQI · Traditional Cordis Corp.06/13/1986SE

More from Cordis Corp.

510(k)DeviceDecision
K894262Rubella Antigen and Control AntigenGON · Traditional 10/16/1989SE
K894261Toxoplasma Gondii-Cf Antigen and Control AntigenGMN · Traditional 10/16/1989SE
K852932Measles-Complement Fix Antigen & Negative CLTGRF · Traditional 11/12/1985SE
K852931Herpes Hominus I-Comple Fix Antigen & Negative CLTGQO · Traditional 11/12/1985SE
K852930Varicella-Zoster-Comple Fix Antigen and Neg ControGQX · Traditional 11/12/1985SE
K852933Mycoplasma SPP Serological ReagentsGSB · Traditional 08/01/1985SE

Questions and answers

When was Cmv-Complement Fixation Antigen and Negative Contr cleared by the FDA?

Cmv-Complement Fixation Antigen and Negative Contr (K852929) received a 510(k) decision of Substantially Equivalent on November 12, 1985, 126 days after the submission was received.

What is the product code of K852929?

The FDA product code is GQI – Antiserum, Cf, Cytomegalovirus, a Class II (moderate risk) device regulated under 21 CFR 866.3175.